Updated therapeutic approach in the management of Polycystic Ovary Syndrome (PCOS): A Review

A. Kaul, N. Zar, Shruti Shangloo, Parminder Nain
{"title":"Updated therapeutic approach in the management of Polycystic Ovary Syndrome (PCOS): A Review","authors":"A. Kaul, N. Zar, Shruti Shangloo, Parminder Nain","doi":"10.21276/ijrdpl.2278-0238.2019.8(2).37-42","DOIUrl":null,"url":null,"abstract":"http://dx.doi.org/10.21276/IJRDPL.22780238.2019.8(2).37-42 ABSTRACT: Polycystic ovary syndrome (PCOS) is a heterogeneous clinical entity that is defined as the association of hyperandrogenism with chronic an ovulation in women without specific underlying diseases of the adrenal or pituitary glands. PCOS is also associated with a metabolic disturbance with complex inter relation of obesity, insulin resistance and endocrine abnormalities remains unresolved. However, several studies link obesity, body fat distribution and nutritional habits with the hormonal and metabolic profiles of PCOS. Moreover, intervention studies have suggested that reducing weight and hyper insulinaemia either by diet alone or by a combination of diet with drugs improves hirsutism, fertility, hormonal and metabolic profiles of PCOS. In fact, the evaluation of nutritional factors in PCOS is helpful for the screening of metabolic abnormalities and the management of women with PCOS. A point of particular interest in the management of PCOS is that the choice of contraception remains difficult in these high cardiovascular risk women. The lack of prospective studies to evaluate long-term metabolic and cardiovascular tolerance necessitates care and the assessment of other hormonal possibilities","PeriodicalId":14211,"journal":{"name":"International Journal of Research and Development in Pharmacy & Life Sciences","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research and Development in Pharmacy & Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/ijrdpl.2278-0238.2019.8(2).37-42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

http://dx.doi.org/10.21276/IJRDPL.22780238.2019.8(2).37-42 ABSTRACT: Polycystic ovary syndrome (PCOS) is a heterogeneous clinical entity that is defined as the association of hyperandrogenism with chronic an ovulation in women without specific underlying diseases of the adrenal or pituitary glands. PCOS is also associated with a metabolic disturbance with complex inter relation of obesity, insulin resistance and endocrine abnormalities remains unresolved. However, several studies link obesity, body fat distribution and nutritional habits with the hormonal and metabolic profiles of PCOS. Moreover, intervention studies have suggested that reducing weight and hyper insulinaemia either by diet alone or by a combination of diet with drugs improves hirsutism, fertility, hormonal and metabolic profiles of PCOS. In fact, the evaluation of nutritional factors in PCOS is helpful for the screening of metabolic abnormalities and the management of women with PCOS. A point of particular interest in the management of PCOS is that the choice of contraception remains difficult in these high cardiovascular risk women. The lack of prospective studies to evaluate long-term metabolic and cardiovascular tolerance necessitates care and the assessment of other hormonal possibilities
多囊卵巢综合征(PCOS)的最新治疗方法:综述
http://dx.doi.org/10.21276/IJRDPL.22780238.2019.8(2).37-42摘要:多囊卵巢综合征(PCOS)是一种异质性临床实体,其定义为无肾上腺或垂体特异性基础疾病的女性高雄激素症与慢性排卵相关。多囊卵巢综合征还与代谢紊乱有关,其与肥胖、胰岛素抵抗和内分泌异常之间的复杂相互关系尚不清楚。然而,一些研究将肥胖、体脂分布和营养习惯与多囊卵巢综合征的激素和代谢特征联系起来。此外,干预研究表明,通过单独饮食或饮食与药物联合减少体重和高胰岛素血症可改善多囊卵巢综合征的多毛症、生育能力、激素和代谢特征。事实上,对PCOS患者的营养因子进行评估有助于PCOS患者代谢异常的筛查和治疗。在多囊卵巢综合征的管理特别感兴趣的一点是,避孕的选择仍然困难,在这些高心血管风险的妇女。由于缺乏评估长期代谢和心血管耐受性的前瞻性研究,因此需要注意和评估其他激素的可能性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信